Dual inhibition of MAT2A and PRMT5 delivers synergistic anti-tumor responses in preclinical models of MTAP-deleted cancer
Marcus M. Fischer,Kimberline Gerrick,Brian Belmontes,Katherine Slemmons,Yevgeniy Freyman,Jay Jain,Steve Federowicz,Isaac Bishof,Arjun A. Rao,Melissa Fleury,Zineb Mounir,Mark R. Lackner,Paul E. Hughes,Mike White,Claire L. Neilan
